HEM Pharma Inc

376270

Company Profile

  • Business description

    HEM Pharma Inc is a microbiome-specialized healthcare company that operates a customized healthcare business and an LBP (Live Biotherapeutic Products) discovery platform business utilizing PMAS (Personalized Pharmaceutical Metal-Analytical Screening), a gut microbiome simulation technology. Its technology includes PMAS, MBR, Multi-omics, Microbiome, and Metabolome.

  • Contact

    558, Handong-ro, Heunghae-eup
    F102ho, 102ho
    Gyeongsangbuk-do
    Buk-gu
    Pohang-si
    KOR

    T: +82 18994258

    https://www.hempharma.bio

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.3022.500.26%
CAC 407,751.8927.83-0.36%
DAX 4023,997.4864.250.27%
Dow JONES (US)42,270.0754.340.13%
FTSE 1008,772.3855.930.64%
HKSE23,289.77283.61-1.20%
NASDAQ19,113.7762.10-0.32%
Nikkei 22537,965.10467.88-1.22%
NZX 50 Index12,418.89137.581.12%
S&P 5005,911.690.48-0.01%
S&P/ASX 2008,434.7024.900.30%
SSE Composite Index3,347.4915.96-0.47%

Market Movers